These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 18328840)

  • 1. Impact of renal insufficiency on angiographic, procedural, and in-hospital outcomes following percutaneous coronary intervention.
    Osten MD; Ivanov J; Eichhofer J; Seidelin PH; Ross JR; Barolet A; Horlick EM; Ing D; Schwartz L; Mackie K; Dzavík V
    Am J Cardiol; 2008 Mar; 101(6):780-5. PubMed ID: 18328840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of moderate or severe renal insufficiency on long-term outcomes in patients undergoing drug-eluting stent based coronary intervention.
    Zhang RY; Zhu ZB; Zhang Q; Yang ZK; Hu J; Lv AK; Zhang JS; Shen WF
    Int J Cardiol; 2009 Jul; 136(1):72-9. PubMed ID: 18653250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of renal insufficiency on outcome after contemporary percutaneous coronary intervention.
    Blackman DJ; Pinto R; Ross JR; Seidelin PH; Ing D; Jackevicius C; Mackie K; Chan C; Dzavik V
    Am Heart J; 2006 Jan; 151(1):146-52. PubMed ID: 16368308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-hospital outcomes of very elderly patients (85 years and older) undergoing percutaneous coronary intervention.
    Appleby CE; Ivanov J; Mackie K; Džavík V; Overgaard CB
    Catheter Cardiovasc Interv; 2011 Apr; 77(5):634-41. PubMed ID: 21387535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term clinical outcomes in patients with moderate renal insufficiency undergoing stent based percutaneous coronary intervention.
    Zhang RY; Ni JW; Zhang JS; Hu J; Yang ZK; Zhang Q; Lü AK; Shen WF
    Chin Med J (Engl); 2006 Jul; 119(14):1176-81. PubMed ID: 16863609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes in patients with renal impairment undergoing percutaneous coronary intervention and implantation of the Endeavor zotarolimus-eluting stent: 1- and 2-year data from the E-Five Registry.
    Rothman MT; Jain AK;
    Catheter Cardiovasc Interv; 2012 Nov; 80(6):885-92. PubMed ID: 22517785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal insufficiency is an independent predictor of mortality after percutaneous coronary intervention.
    Naidu SS; Selzer F; Jacobs A; Faxon D; Marks DS; Johnston J; Detre K; Wilensky RL
    Am J Cardiol; 2003 Nov; 92(10):1160-4. PubMed ID: 14609589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction.
    Sadeghi HM; Stone GW; Grines CL; Mehran R; Dixon SR; Lansky AJ; Fahy M; Cox DA; Garcia E; Tcheng JE; Griffin JJ; Stuckey TD; Turco M; Carroll JD
    Circulation; 2003 Dec; 108(22):2769-75. PubMed ID: 14638545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of renal failure on all-cause mortality and other outcomes in patients treated by percutaneous coronary intervention.
    Loncar G; Barthelemy O; Berman E; Kerneis M; Petroni T; Payot L; Choussat R; Silvain J; Collet JP; Helft G; Montalescot G; Le Feuvre C
    Arch Cardiovasc Dis; 2015 Nov; 108(11):554-62. PubMed ID: 26184868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of renal insufficiency on safety and efficacy of drug-eluting stents compared to bare-metal stents at 6 years.
    Simsek C; Magro M; Boersma E; Onuma Y; Nauta S; Valstar G; van Geuns RJ; van der Giessen W; van Domburg R; Serruys P;
    Catheter Cardiovasc Interv; 2012 Jul; 80(1):18-26. PubMed ID: 21735520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does proximal location of culprit lesion confer worse prognosis in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction?
    Harjai KJ; Mehta RH; Stone GW; Boura JA; Grines L; Brodie BR; Cox DA; O'Neill WW; Grines CL;
    J Interv Cardiol; 2006 Aug; 19(4):285-94. PubMed ID: 16881971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of unprotected left main disease with drug-eluting stents in patients at high risk for coronary artery bypass grafting.
    Barlis P; Horrigan M; Elis S; Chan R; Wong M; Farouque O; Proimos G; Ajani AE; Clark DJ
    Cardiovasc Revasc Med; 2007; 8(2):84-9. PubMed ID: 17574165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of peripheral arterial disease in patients undergoing percutaneous coronary intervention with intracoronary stents.
    Singh M; Lennon RJ; Darbar D; Gersh BJ; Holmes DR; Rihal CS
    Mayo Clin Proc; 2004 Sep; 79(9):1113-8. PubMed ID: 15357032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of coronary revascularization (percutaneous or bypass) in patients with diabetes mellitus and multivessel coronary disease.
    Hee L; Mussap CJ; Yang L; Dignan R; Kadappu KK; Juergens CP; Thomas L; French JK
    Am J Cardiol; 2012 Sep; 110(5):643-8. PubMed ID: 22632829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization.
    Lenzen MJ; Boersma E; Bertrand ME; Maier W; Moris C; Piscione F; Sechtem U; Stahle E; Widimsky P; de Jaegere P; Scholte op Reimer WJ; Mercado N; Wijns W;
    Eur Heart J; 2005 Jun; 26(12):1169-79. PubMed ID: 15802360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of percutaneous coronary interventions in patients > or =90 years of age.
    Teplitsky I; Assali A; Lev E; Brosh D; Vaknin-Assa H; Kornowski R
    Catheter Cardiovasc Interv; 2007 Dec; 70(7):937-43. PubMed ID: 17621664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes after percutaneous coronary intervention in patients with mild versus moderate renal insufficiency at 30-day and 1-year follow-up.
    Singh M; Singh P; Grewal P; Kovacs D; Molnar J; Arora R; Khosla S
    Am J Ther; 2014; 21(3):184-92. PubMed ID: 23817344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of previous revascularization on clinical outcomes in patients undergoing primary percutaneous coronary intervention.
    Bench TJ; Parikh PB; Jeremias A; Brener SJ; Naidu SS; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    J Invasive Cardiol; 2013 Apr; 25(4):166-9. PubMed ID: 23549488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contemporary incidence and predictors of major adverse cardiac events after saphenous vein graft intervention with embolic protection (an AMEthyst trial substudy).
    Naidu SS; Turco MA; Mauri L; Coolong A; Popma JJ; Kereiakes DJ
    Am J Cardiol; 2010 Apr; 105(8):1060-4. PubMed ID: 20381653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.